Back to FDA Applications sponsored by MEDIMMUNE ONCOLOGY

FDA Drug Application 020326 by MEDIMMUNE ONCOLOGY

Application Number020326
Application Type New Drug Application
Sponsor ApplicantMEDIMMUNE ONCOLOGY
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority*
Orphan CodeV


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP012/17/1993N       
AP03/4/1994SCS       
AP05/9/1995SCM       
AP05/9/1995SCP       
AP05/9/1995SCP       
AP05/13/1996SCS       
AP01/21/1997SCM       
AP08/5/1997SLR       
AP08/28/1997SCM       
AP08/5/1997SLR       
AP07/31/1998SCS       
AP06/26/2002SLR2945011   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20326s011,013ltr.pdf 6/26/2002
AP06/26/2002SLR2946011   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20326s11s13lbl.pdf 6/26/2002
AP06/26/2002SLR2947013   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20326s011,013ltr.pdf 6/26/2002
AP06/26/2002SLR2948013   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20326s11s13lbl.pdf 6/26/2002
AP011/9/2005SLR13061015   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020326s015lbl.pdf 11/17/2005
AP011/9/2005SLR13081015   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020326s015ltr.pdf 11/18/2005




Back to FDA Applications sponsored by MEDIMMUNE ONCOLOGY

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.